BIM
NXTM

BlackRock Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

BlackRock Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.24M Sell
238,118
-715
-0.3% -$17.7K 0.01% 1433
2016
Q3 		$5.97M Buy
238,833
+2,253
+1% +$52.5K 0.01% 1355
2016
Q2 		$5.13M Buy
236,580
+20,206
+9% +$361K 0.01% 1412
2016
Q1 		$3.24M Buy
216,374
+3,578
+2% +$60K ﹤0.01% 1665
2015
Q4 		$4.66M Buy
212,796
+964
+0.5% +$18K 0.01% 1442
2015
Q3 		$3.34M Sell
211,832
-4,495
-2% -$72.1K ﹤0.01% 1666
2015
Q2 		$3.09M Buy
216,327
+46,209
+27% +$783K ﹤0.01% 1882
2015
Q1 		$2.94M Buy
170,118
+3,488
+2% +$61.6K ﹤0.01% 1763
2014
Q4 		$2.99M Sell
166,630
-2,028
-1% -$32.7K ﹤0.01% 1742
2014
Q3 		$2.21M Buy
168,658
+984
+0.6% +$13.3K ﹤0.01% 1926
2014
Q2 		$2.41M Buy
167,674
+2,295
+1% +$30K ﹤0.01% 1939
2014
Q1 		$2.11M Buy
165,379
+1,408
+0.9% +$18.4K ﹤0.01% 2001
2013
Q4 		$1.64M Sell
163,971
-5,100
-3% -$57.9K ﹤0.01% 2162
2013
Q3 		$2.23M Buy
169,071
+11,704
+7% +$154K ﹤0.01% 1878
2013
Q2 		$2.25M Buy
+157,367
New +$1.98M ﹤0.01% 1773

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BlackRock Investment Management's NXTM Position: Q4 2016 in Review

BlackRock Investment Management reduced its NxStage Medical Inc. (NXTM) stake by 0.3% in Q4 2016, selling an estimated $17.7K and leaving 238,118 shares worth $6.24M. The position accounts for 0.01% of the portfolio, ranked #1433.

BlackRock Investment Management first reported a position in NXTM in Q2 2013 and has held it in 15 quarters since. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

  • BlackRock Investment Management held 238,118 shares of NxStage Medical Inc. worth $6.24M as of Q4 2016.
  • BlackRock Investment Management sold 715 NxStage Medical Inc. shares in Q4 2016, an estimated $17.7K.
  • NxStage Medical Inc. made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1433 holding.
  • BlackRock Investment Management first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 15 quarters since.
  • 170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.